Systemic sclerosis
115 results
1 - 100
Exercise and physical therapy for systemic sclerosis- Prazosin for Raynaud's phenomenon in progressive systemic sclerosis
- Stem cell transplantation for systemic sclerosis
- Ketanserin for Raynaud's phenomenon in progressive systemic sclerosis
- Iloprost and cisaprost for Raynaud's phenomenon in progressive systemic sclerosis
- Cyclofenil for Raynaud's phenomenon in progressive systemic sclerosis
- Interferon in relapsing‐remitting multiple sclerosis
- Intravenous immunoglobulins for multiple sclerosis
- Methotrexate for multiple sclerosis
- Anti‐spasticity agents for multiple sclerosis
- Laquinimod for multiple sclerosis: Cochrane systematic review
- Drug therapy for pain in amyotrophic lateral sclerosis or motor neuron disease
- Cyclophosphamide for multiple sclerosis
- Occupational therapy for multiple sclerosis
- Hyperbaric oxygen therapy for multiple sclerosis
- Mycophenolate mofetil for relapsing-remitting multiple sclerosis: Cochrane systematic review
- Immunomodulators and immunosuppressants for progressive multiple sclerosis: a network meta‐analysis
- Statins for multiple sclerosis: Cochrane systematic review
- Immunomodulators and immunosuppressants for relapsing‐remitting multiple sclerosis: a network meta‐analysis
- Rapamycin and rapalogs for tuberous sclerosis complex
- Exercise therapy for multiple sclerosis: Cochrane systematic review
- Treatment for ataxia in multiple sclerosis
- Oral versus intravenous steroids for treatment of relapses in multiple sclerosis
- Ocrelizumab for multiple sclerosis
- Recombinant interferon beta or glatiramer acetate for delaying conversion of the first demyelinating event to multiple sclerosis
- Dimethyl fumarate for multiple sclerosis: Cochrane systematic review
- Therapeutic exercise for people with amyotrophic lateral sclerosis or motor neuron disease: Cochrane systematic review
- Dietary interventions for multiple sclerosis‐related outcomes
- Siponimod for multiple sclerosis
- Telerehabilitation for persons with multiple sclerosis
- Alemtuzumab for multiple sclerosis
- Adverse effects of immunotherapies for multiple sclerosis: a network meta‐analysis
- Interventions for preventing falls in people with multiple sclerosis
- Corticosteroids or ACTH for acute exacerbations in multiple sclerosis: Cochrane systematic review
- Mitoxantrone for multiple sclerosis: Cochrane systematic review
- Sodium channel blockers for neuroprotection in multiple sclerosis
- alemtuzumab versus interferon beta 1a for relapsing‐remitting multiple sclerosis
- Respiratory muscle training for multiple sclerosis
- Virtual reality for multiple sclerosis rehabilitation
- Exercise therapy for fatigue in multiple sclerosis
- Rituximab for people with multiple sclerosis
- Cannabis and cannabinoids for symptomatic treatment for people with multiple sclerosis
- Neuropsychological rehabilitation for multiple sclerosis: Cochrane systematic review
- Pharmacological treatment for memory disorder in multiple sclerosis: Cochrane systematic review
- Vitamin D for the management of multiple sclerosis
- Non pharmacological interventions for spasticity in multiple sclerosis: Cochrane systematic review
- Cyclophosphamide for connective tissue disease–associated interstitial lung disease
- Azathioprine for people with multiple sclerosis
- Daclizumab for relapsing remitting multiple sclerosis
- Effectiveness of vocational rehabilitation intervention on the return to work and employment of persons with multiple sclerosis
- Glatiramer acetate for multiple sclerosis
- Immunomodulators and immunosuppressants for multiple sclerosis: a network meta‐analysis
- Phosphodiesterase 5 inhibitors (PDE5i) for the treatment of Raynaud's phenomenon
- Whole-body vibration training for patients with neurodegenerative disease: Cochrane systematic review
- Palliative care interventions for people with multiple sclerosis
- Rituximab for relapsing-remitting multiple sclerosis: Cochrane systematic review
- Information provision for people with multiple sclerosis
- Fingolimod for relapsing‐remitting multiple sclerosis
- Natalizumab for relapsing remitting multiple sclerosis: Cochrane systematic review
- Percutaneous transluminal angioplasty for treatment of chronic cerebrospinal venous insufficiency (CCSVI) in people with multiple sclerosis
- Probiotics for preventing urinary tract infection in people with neuropathic bladder
- Teriflunomide for multiple sclerosis
- Treatment with disease‐modifying drugs for people with a first clinical attack suggestive of multiple sclerosis